Literature DB >> 1390497

Lid melanoma and parkinsonism.

S A Haider1, V T Thaller.   

Abstract

This is a case report of a patient with parkinsonism on levodopa therapy who developed a lid margin melanoma. The possible association is discussed.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1390497      PMCID： PMC504240          DOI： 10.1136/bjo.76.4.246

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  10 in total

1.  L-dopa: selective toxicity for melanoma cells in vitro.

Authors:  M M Wick; L Byers; E Frei
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

2.  Development of two malignant melanomas during administration of levodopa.

Authors:  B Przybilla; U Schwab; M Landthaler; O Braun-Falco
Journal:  Acta Derm Venereol       Date:  1985       Impact factor: 4.437

3.  Levodopa and melanoma.

Authors:  A N Lieberman; J L Shupack
Journal:  Neurology       Date:  1974-04       Impact factor: 9.910

4.  Multiple primary melanoma following administration of levodopa.

Authors:  J L Skibba; J Pinckley; E F Gilbert; R O Johnson
Journal:  Arch Pathol       Date:  1972-06

5.  Levodopa and melanoma: three cases and review of literature.

Authors:  F H Rampen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

6.  Uveal malignant melanoma and levodopa therapy in Parkinson's disease.

Authors:  G H Van Rens; P T De Jong; E E Demols; M F Brihaye-Van Geertruyden
Journal:  Ophthalmology       Date:  1982-12       Impact factor: 12.079

7.  Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature.

Authors:  A S Kochar
Journal:  Am J Med       Date:  1985-07       Impact factor: 4.965

8.  Enhancement of L-dopa incorporation into melanoma by dopa decarboxylase inhibition.

Authors:  M M Wick; R A Kramer; M Gorman
Journal:  J Invest Dermatol       Date:  1978-06       Impact factor: 8.551

9.  Levodopa therapy and malignant melanoma.

Authors:  A J Sober; M M Wick
Journal:  JAMA       Date:  1978-08-11       Impact factor: 56.272

10.  Levodopa administration and multiple primary cutaneous melanomas.

Authors:  J E Bernstein; M Medenica; K Soltani; A Solomon; A L Lorincz
Journal:  Arch Dermatol       Date:  1980-09
  10 in total
  2 in total

1.  Parkinson Disease and Melanoma: Confirming and Reexamining an Association.

Authors:  Lauren A Dalvin; Gena M Damento; Barbara P Yawn; Barbara A Abbott; David O Hodge; Jose S Pulido
Journal:  Mayo Clin Proc       Date:  2017-07       Impact factor: 7.616

Review 2.  The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers.

Authors:  Rivka Inzelberg; Simon D Israeli-Korn
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.